Uveitis Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2023 Update
Powered by
All the vital news, analysis, and commentary curated by our industry experts.
Uveitis Clinical Trials Market Report Overview
The uveitis clinical trial market research report provides an overview of the uveitis clinical trials scenario. The report provides top-line data relating to the clinical trials on uveitis. It also includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. Moreover, it offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status, and sponsor type.
Key Regions | North America, Europe, Asia-Pacific, Middle East & Africa, and South & Central America |
Key Countries | The US, Germany, The UK, China, France, India, Spain, Japan, Italy, and Israel |
Key Sponsor Types | Institution, Company, and Government |
Leading Sponsors | Novartis AG, AbbVie Inc, EyePoint Pharmaceuticals Inc, F. Hoffmann-La Roche Ltd, Bausch Health Companies Inc, IQVIA Holdings Inc, XOMA Corp, Alcon Inc, Clearside BioMedical Inc, and Les Laboratoires Servier SAS |
Enquire & Decide | Discover the perfect solution for your business needs. Enquire now and let us help you make an informed decision before making a purchase. |
Uveitis Clinical Trials Market Segmentation by Regions and Countries
The key regions in the uveitis clinical trials market are North America, Europe, Asia-Pacific, Middle East & Africa, and South & Central America. North America led with more than 30% of the clinical trials conducted as of July 2023.
In a country-wise analysis, as of July 2023, the US has the highest number of uveitis clinical trials, followed by Germany, the United Kingdom, China, India, France, Spain, Japan, Israel, and Italy.
G7 countries: Among the G7 (United States, United Kingdom, Germany, France, Italy, Canada, and Japan) countries, the UK has the highest proportion of uveitis to ophthalmology clinical trials. Moreover, out of all the clinical trials conducted in the G7 countries, the majority were in the US.
E7 countries: Among the E7 (Brazil, Russia, India, China, Mexico, Turkey, and Indonesia) countries, Indonesia has the highest proportion of uveitis to ophthalmology clinical trials. Out of all the clinical trials conducted in the E7 countries, the majority were in China.
Uveitis Clinical Trials Analysis by Regions, 2023 (%)
For more regional insights into the uveitis clinical trials market, download a free report sample
Uveitis Clinical Trials Market Segmentation by Sponsor Types
The key sponsor types in the uveitis clinical trials market are institution, company, and the government. In July 2023, the company sponsor type dominated the uveitis clinical trials market share, followed by institution.
Uveitis Clinical Trials Market Analysis by Sponsor Types, 2023 (%)
For more sponsor type insights into the uveitis clinical trials market, download a free report sample
Uveitis Clinical Trials Market - Competitive Landscape
The leading sponsors in the uveitis clinical trials market are Novartis AG, AbbVie Inc, F. Hoffmann-La Roche Ltd, XOMA Corp, Bausch Health Companies Inc, Alcon Inc, EyePoint Pharmaceuticals Inc, IQVIA Holdings Inc, Les Laboratoires Servier SAS, and Clearside BioMedical Inc. In 2023, Novartis AG has conducted the highest number of uveitis clinical trials.
Uveitis Clinical Trials Market Analysis by Sponsors, 2023 (%)
To know more about the leading players in the uveitis clinical trials market, download a free report sample
Scope
- The report provides a snapshot of the global clinical trials landscape.
- The report provides top-level data related to the clinical trials by region, country (G7 & E7), trial status, trial phase, sponsor type, and endpoint status.
- The report reviews the top companies involved and enlists all trials (trial title, phase, and status) pertaining to the company.
- The report provides all the unaccomplished trials (terminated, suspended, and withdrawn) with a reason for unaccomplishment
- The report provides enrollment trends for the past five years.
- The report provides the latest news for the past three months.
Reasons to Buy
- Assists in formulating key business strategies concerning investment.
- Helps in identifying prominent locations for conducting clinical trials which saves time and cost.
- Provides top-level analysis of the global clinical trials market which helps in identifying key business opportunities.
- Supports understanding of trials count and enrollment trends by country in the global therapeutics market.
- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended, or withdrawn) trials.
- Facilitates clinical trial assessment of the indication on a global, regional, and country level.
AbbVie Inc
F. Hoffmann-La Roche Ltd
Alcon Inc
Bausch Health Companies Inc
EyePoint Pharmaceuticals Inc
IQVIA Holdings Inc
XOMA Corp
Clearside BioMedical Inc
Les Laboratoires Servier SAS
Table of Contents
Table
Figures
Frequently asked questions
-
Which was the dominating region in the uveitis clinical trials market?
North America was the dominating region in the uveitis clinical trials market as of July 2023.
-
Which country was contributing the highest number in the uveitis clinical trials?
The US accounted for the highest number of uveitis clinical trials as of July 2023.
-
Which sponsor type was the most prominent in the uveitis clinical trials market?
The company sponsor type led the uveitis clinical trials market.
-
Who are the leading sponsors in the uveitis clinical trials market?
The leading sponsors in the uveitis clinical trials market are Novartis AG, AbbVie Inc, EyePoint Pharmaceuticals Inc, F. Hoffmann-La Roche Ltd, Bausch Health Companies Inc, IQVIA Holdings Inc, XOMA Corp, Alcon Inc, Clearside BioMedical Inc, and Les Laboratoires Servier SAS.
Get in touch to find out about multi-purchase discounts
reportstore@globaldata.com
Tel +44 20 7947 2745
Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.